Regulation of breast cancer cell chemotaxis by the phosphoinositide 3-kinase p110δ1

Cancer Research

Volumn 63, Issue 7, 2003, Pages 1667-1675

  Sawyer, Carol ^a   Sturge, Justin ^b,g   Bennett, Dorothy C ^c   O'Hare, Michael J ^d   Allen, William E ^e   Bain, Jennifer ^f   Jones, Gareth E ^b   Vanhaesebroeck, Bart ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^d LUDWIG INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^e QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^f UNIVERSITY OF DUNDEE   (United Kingdom)

^g INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; ISOENZYME; NEUTRALIZING ANTIBODY; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE KINASE; RAS PROTEIN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL ASSAY; CELL MIGRATION; CELL TRANSFORMATION; CELL TYPE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LEUKOCYTE; MICROINJECTION; NUCLEOTIDE SEQUENCE; PARAMETER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; TISSUE DISTRIBUTION; VELOCITY;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; BREAST NEOPLASMS; CELL MOVEMENT; CHEMOTAXIS; HUMANS; ISOENZYMES; MELANOCYTES; MELANOMA; MICE; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0037381002     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Fruman, D. A., Meyers, R. E., and Cantley, L. C. Phosphoinositide kinases. Annu. Rev. Biochem., 67: 481-507, 1998.
2. Backer, J. M. Phosphoinositide 3-kinases and the regulation of vesicular trafficking. Mol. Cell. Biol. Res. Comm., 3: 193-204, 2000.
3. Vanhaesebroeck, B., Leevers, S. J., Ahmadi, K., Timms, J., Katso, R., Driscoll, P. C., Woscholski, R., Parker, P. J., and Waterfield, M. D. Synthesis and function of 3-phosphorylated inositol lipids. Annu. Rev. Biochem., 70: 535-602, 2001.
4. Cantley, L. C. The phosphoinositide 3-kinase pathway. Science (Wash. DC), 296: 1655-1657, 2002.
5. Bos, J. L. Ras oncogenes in human cancer: a review. Cancer Res., 49: 4682-4689, 1989.
6. Blume-Jensen, P., and Hunter, T. Oncogenic kinase signalling. Nature (Lond.), 411: 355-365, 2001.
7. Gire, V., Marshall, C., and Wynford-Thomas, D. PI-3-kinase is an essential antiapoptotic effector in the proliferative response of primary human epithelial cells to mutant RAS. Oncogene, 19: 2269-2276, 2000.
8. Kung, H-J., (Ed.) Tyrosine kinases. Oncogene (Reviews), 18: 5447-5701, 2000.
9. Scheid, M. P., and Woodgett, J. R. Phosphatidylinositol 3′ kinase signaling in mammary tumorigenesis. J. Mammary Gland Biol. Neoplasia, 6: 83-99, 2001.
10. Kandel, E. S., and Hay, N. The regulation and activities of the multifunctional Serine/Threonine kinase Akt/PKB. Exp. Cell Res., 253: 210-229, 1999.
11. Scheid, M. P., and Woodgett, J. R. PKB/Akt: functional insights from genetic models. Nat. Rev. Mol. Cell. Biol., 2: 760-768, 2001.
12. Vivanco, I., and Sawyers, C. L. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat. Rev. Cancer, 2: 489-501, 2002.
13. Cantley, L. C., and Neel, B. G. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc. Natl. Acad. Sci. USA, 96: 4240-4245, 1999.
14. Di Cristofano, A., and Pandolfi, P. P. The multiple roles of PTEN in tumor suppression. Cell, 100: 387-390, 2000.
15. Maehama, T., Taylor, G. S., and Dixon, J. E. PTEN and myotubularin: Novel phosphoinositide phosphatases. Annu. Rev. Biochem., 70: 247-279, 2001.
16. Vanhaesebroeck, B., Leevers, S. J., Panayotou, G., and Waterfield, M. D. Phosphoinositide 3-kinases: a conserved family of signal transducers. Trends Biochem. Sci., 22: 267-272, 1997.
17. Rodriguez-Viciana, P., Warne, P. H., Dhand, R., Vanhaesebroeck, B., Gout, I., Fry, M. J., Waterfield, M. D., and Downward, J. Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature (Lond.), 370: 527-532, 1994.
18. Kodaki, T., Woscholski, R., Hallberg, B., Rodriguez-Viciana, P., Downward, J., and Parker, P. J. The activation of phosphatidylinositol 3-kinase by Ras. Curr. Biol., 4: 798-806, 1994.
19. Vanhaesebroeck, B., and Waterfield, M. D. Signaling by distinct classes of phosphoinositide 3-kinases. Exp. Cell Res., 253: 239-254, 1999.
20. Roche, S., Koegl, M., and Courtneidge, S. A. The phosphatidylinositol 3-kinase a is required for DNA synthesis induced by some, but not all, growth factors. Proc. Natl. Acad. Sci. USA, 91: 9185-9189, 1994.
21. McIlroy, J., Chen, D., Wjasow, C., Michaeli, T., and Backer, J. M. Specific activation of p85-p110 phosphatidylinositol 3′-kinase stimulates DNA synthesis by ras- and p70 S6 kinase-dependent pathways. Mol. Cell. Biol., 17: 248-255, 1997.
22. Siddhanta, U., McIlroy, J., Shah, A., Zhang, Y., and Backer, J. M. Distinct roles for the p110α and hVPS34 phosphatidylinositol 3′-kinases in vesicular trafficking, regulation of the actin cytoskeleton, and mitogenesis. J. Cell Biol., 143: 1647-1659, 1998.
23. Roche, S., Downward, J., Raynal, P., and Courtneidge, S. A. A function for phosphatidylinositol 3-kinase β (p85a-p110β) in fibroblasts during mitogenesis: requirement for insulin- and lysophosphatidic acid-mediated signal transduction. Mol. Cell. Biol., 18: 7119-7129, 1998.
24. Vanhaesebroeck, B., Jones, G. E., Allen, W. E., Zicha, D., Hooshmand-Rad, R., Sawyer, C., Wells, C., Waterfield, M. D., and Ridley, A. J. Distinct PI(3)Ks mediate mitogenic signalling and cell migration in macrophages. Nat. Cell Biol., 1: 69-71, 1999.
25. Benistant, C., Chapuis, H., and Roche, S. A specific function for phosphatidylinositol 3-kinase α (p85α-p110α) in cell survival and for phosphatidylinositol 3-kinase β (p85α-p110β) in de novo DNA synthesis of human colon carcinoma cells. Oncogene, 19: 5083-5090, 2000.
26. Hill, K., Welti, S., Yu, J., Murray, J. T., Yip, S. C., Condeelis, J. S., Segall, J. E., and Backer, J. M. Specific requirement for the p85-p110α phosphatidylinositol 3-kinase during epidermal growth factor-stimulated actin nucleation in breast cancer cells. J. Biol. Chem., 275: 3741-3744, 2000.
27. Hooshmand-Rad, R., Hajkova, L., Klint, P., Karlsson, R., Vanhaesebroeck, B., Claesson-Welsh, L., and Heldin, C. H. The PI 3-kinase isoforms p110(α) and p110(β) have differential roles in PDGF- and insulin-mediated signaling. J. Cell Sci., 113: 207-214, 2000.
28. Shayesteh, L., Lu, Y., Kuo, W. L., Baldocchi, R., Godfrey, T., Collins, C., Pinkel, D., Powell, B., Mills, G. B., and Gray, J. W. PIK3CA is implicated as an oncogene in ovarian cancer. Nat. Genet., 21: 99-102, 1999.
29. Ma, Y. Y., Wei, S. J., Lin, Y. C., Lung, J. C., Chang, T. C., Whang-Peng, J., Liu, J. M., Yang, D. M., Yang, W. K., and Shen, C. Y. PIK3CA as an oncogene in cervical cancer. Oncogene, 19: 2739-2744, 2000.
30. Redon, R., Muller, D., Caulee, K., Wanherdrick, K., Abecassis, J., and du Manoir, S. A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains. Cancer Res., 61: 4122-4129, 2001.
31. Philp, A. J., Campbell, I. G., Leet, C., Vincan, E., Rockman, S. P., Whitehead, R. H., Thomas, R. J., and Phillips, W. A. The phosphatidylinositol 3′-kinase p85α gene is an oncogene in human ovarian and colon tumors. Cancer Res., 61: 7426-7429, 2001.
32. Chang, H. W., Aoki, M., Fruman, D., Auger, K. R., Bellacosa, A., Tsichlis, P. N., Cantley, L. C., Roberts, T. M., and Vogt, P. K. Transformation of chicken cells by the gene encoding the catalytic subunit of PI 3-kinase. Science (Wash. DC), 276: 1848-1850, 1997.
33. Jimenez, C., Jones, D. R., Rodriguez-Viciana, P., Gonzalez-Garcia, A., Leonardo, E., Wennstrom, S., von Kobbe, C., Toran, J. L., L, R. B., Calvo, V., Copin, S. G., Albar, J. P., Gaspar, M. L., Diez, E., Marcos, M. A., Downward, J., Martinez, A. C., Merida, I., and Carrera, A. C. Identification and characterization of a new oncogene derived from the regulatory subunit of phosphoinositide 3-kinase. EMBO J., 17: 743-753, 1998.
34. Aoki, M., Schetter, C., Himly, M., Batista, O., Chang, H. W., and Vogt, P. K. The catalytic subunit of phosphoinositide 3-kinase: requirements for oncogenicity. J. Biol. Chem., 275: 6267-6275, 2000.
35. Chantry, D., Vojtek, A., Kashishian, A., Holtzman, D. A., Wood, C., Gray, P. W., Cooper, J. A., and Hoekstra, M. F. p110δ, a novel phosphatidylinositol 3-kinase catalytic subunit that associates with p85 and is expressed predominantly in leukocytes. J. Biol. Chem., 272: 19236-41, 1997.
36. Vanhaesebroeck, B., Welham, M. J., Kotani, K., Stein, R., Wame, P. H., Zvelebil, M. J., Higashi, K., Volinia, S., Downward, J., and Waterfield, M. D. P110δ, a novel phosphoinositide 3-kinase in leukocytes. Proc. Natl. Acad. Sci. USA, 94: 4330-4335, 1997.
37. Altschul, S. F., Gish, W., Miller, W., Myers, E. W., and Lipman, D. J. Basic local alignment search tool. J. Mol. Biol., 215: 403-410, 1990.
38. Page, M. J., Amess, B., Townsend, R. R., Parekh, R., Herath, A., Brusten, L., Zvelebil, M. J., Stein, R. C., Waterfield, M. D., Davies, S. C., and O'Hare, M. J. Proteomic definition of normal human luminal and myoepithelial breast cells purified from reduction mammoplasties. Proc. Natl. Acad. Sci. USA, 96: 12589-94, 1999.
39. Bennett, D. C., Cooper, P. J., and Hart, I. R. A line of non-tumorigenic mouse melanocytes, syngeneic with the B16 melanoma and requiring a tumour promoter for growth. Int. J. Cancer, 39: 414-418, 1987.
40. Sviderskaya, E. V., Bennett, D. C., Ho, L., Bailin, T., Lee, S. T., and Spritz, R. A. Complementation of hypopigmentation in p-mutant (pink-eyed dilution) mouse melanocytes by normal human P cDNA, and defective complementation by OCA2 mutant sequences. J. Investig. Dermatol., 108: 30-34, 1997.
41. Dooley, T. P., Wilson, R. E., Jones, N. C., and Hart, I. R. Polyoma middle T abrogates TPA requirement of murine melanocytes and induces malignant melanoma. Oncogene, 3: 531-535, 1988.
42. Wilson, R. E., Dooley, T. P., and Hart, I. R. Induction of tumorigenicity and lack of in vitro growth requirement for 12- O-tetradecanoylphorbol-13-acetate by transfection of murine melanocytes with v-Ha-ras. Cancer Res., 49: 711-716, 1989.
43. Zicha, D., Dunn, G. A., and Brown, A. F. A new direct-viewing chemotaxis chamber. J. Cell Sci., 99: 769-775, 1991.
44. Allen, W. E., Zicha, D., Ridley, A. J., and Jones, G. E. A role for Cdc42 in macrophage chemotaxis. J. Cell Biol., 141: 1147-1157, 1998.
45. Jones, G. E., Ridley, A. J., and Zicha, D. Rho GTPases and cell migration: measurement of macrophage chemotaxis. Methods Enzymol., 325: 449-462, 2000.
46. Hu, P., Mondino, A., Skolnik, E. Y., and Schlessinger, J. Cloning of a novel, ubiquitously expressed human phosphatidylinositol 3-kinase and identification of its binding sitc on p85. Mol. Cell. Biol., 13: 7677-7688, 1993.
47. Bi, L., Okabe, I., Bernard, D. J., Wynshaw-Boris, A., and Nussbaum, R. L. Proliferative defect and embryonic lethality in mice homozygous for a deletion in the p110α subunit of phosphoinositide 3-kinase. J. Biol. Chem., 274: 10963-8, 1999.
48. Zhang, R. D., Fidler, I. J., and Price, J. E. Relative malignant potential of human breast carcinoma cell lines established from pleural effusions and a brain metastasis. Invasion Metastasis, 11: 204-215, 1991.
49. Sturge, J., Hamelin, J., and Jones, G. E. N-WASP activation by a β1-integrindependent mechanism supports PI3K- independent chemotaxis stimulated by urokinase-type plasminogen activator. J. Cell Sci., 115: 699-711, 2002.
50. Olayioye, M. A., Neve, R. M., Lane, H. A., and Hynes, N. E. The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J., 19: 3159-3167, 2000.
51. Bange, J., Zwick, E., and Ullrich, A. Molecular targets for breast cancer therapy and prevention. Nat. Med., 7: 548-552, 2001.
52. Okkenhaug, K., Bilancio, A., Farjot, G., Priddle, H., Sancho, S., Peskett, E., Pearce, W., Meek, S. E., Salpekar, A., Waterfield, M. D., Smith, A. J., and Vanhaesebroeck, B. Impaired B and T cell antigen receptor signaling in p110δ PI 3-kinase mutant mice. Science (Wash. DC), 297: 1031-1034, 2002.
53. Ho, L. K., Liu, D., Rozycka, M., Brown, R. A., and Fry, M. J. Identification of four novel human phosphoinositide 3-kinases defines a multi-isoform subfamily. Biochem. Biophys. Res. Commun., 235: 130-137, 1997.
54. Hansen, R. K., and Bissell, M. J. Tissue architecture and breast cancer: the role of extracellular matrix and steroid hormones. Endocr. Relat. Cancer, 7: 95-113, 2000.
55. Kumar, R., Vadlamudi, R. K., and Adam, L. Apoptosis in mammary gland and cancer. Endocr. Relat. Cancer, 7: 257-269, 2000.
56. Muller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., Barrera, J. L., Mohar, A., Verastegui, E., and Zlotnik, A. Involvement of chemokine receptors in breast cancer metastasis. Nature (Lond.), 410: 50-56, 2001.
57. Moore, M. A. The role of chemoattraction in cancer metastases. Bioessays, 23: 674-676, 2001.
58. Iijima, M., and Devreotes, P. Tumor suppressor PTEN mediates sensing of chemoattractant gradients. Cell, 109: 599-610, 2002.
59. Wang, F., Herzmark, P., Weiner, O. D., Srinivasan, S., Servant, G., and Bourne, H. R. Lipid products of PI(3)Ks maintain persistent cell polarity and directed motility in neutrophils. Nat. Cell Biol., 4: 513-518, 2002.
60. Weiner, O. D., Neilsen, P. O., Prestwich, G. D., Kirschner, M. W., Cantley, L. C., and Boume, H. R. A PtdInsP(3)- and Rho GTPase-mediated positive feedback loop regulates neutrophil polarity. Nat. Cell Biol., 4: 509-513, 2002.
61. Condliffe, A. M., and Hawkins, P. T. Cell biology: moving in mysterious ways. Nature (Lond.), 404: 135-137, 2000.
62. Rickert, P., Weiner, O. D., Wang, F., Bourne, H. R., and Servant, G. Leukocytes navigate by compass: roles of PI3Kγ and its lipid products. Trends Cell Biol., 10: 466-473, 2000.
63. Firtel, R. A., and Chung, C. Y. The molecular genetics of chemotaxis: sensing and responding to chemoattractant gradients. Bioessays, 22: 603-615, 2000.
64. Wymann, M. P., Sozzani, S., Altruda, F., Mantovani, A., and Hirsch, E. Lipids on the move: phosphoinositide 3-kinases in leukocyte function. Immunol. Today, 21: 260-264, 2000.
65. Vanhaesebroeck, B., Higashi, K., Raven, C., Welham, M., Anderson, S., Brennan, P., Ward, S. G., and Waterfield, M. D. Autophosphorylation of p110δ phosphoinositide 3-kinase: a new paradigm for the regulation of lipid kinases in vitro and in vivo. EMBO J., 18: 1292-302, 1999.
66. Deora, A. A., Win, T., Vanhaesebroeck, B., and Lander, H. M. A redox-triggered ras-effector interaction. Recruitment of phosphatidylinositol 3′-kinase to Ras by redox stress. J. Biol. Chem., 273: 29923-8, 1998.
67. Kinashi, T., Katagiri, K., Watanabe, S., Vanhaesebroeck, B., Downward, J., and Takatsu, K. Distinct mechanisms of α5β1 integrin activation by Ha-Ras and R-Ras. J. Biol. Chem., 275: 22590-6, 2000.
68. Carpenter, C. L., Auger, K. R., Duckworth, B. C., Hou, W. M., Schaffhausen, B., and Cantley, L. C. A tightly associated serine/threonine protein kinase regulates phosphoinositide 3-kinase activity. Mol. Cell. Biol., 13: 1657-1665, 1993.
69. Dhand, R., Hiles, I., Panayotou, G., Roche, S., Fry, M. J., Gout, I., Totty, N. F., Truong, O., Vicendo, P., Yonezawa, K., and et al. PI 3-kinase is a dual specificity enzyme: autoregulation by an intrinsic protein-serine kinase activity. EMBO J., 13: 522-533, 1994.